期刊： JOURNAL OF BREAST CANCER, 2021; 24 (2)
Tumor localization in patients receiving neoadjuvant chemotherapy (NACT) is challenging because substantial therapeutic remission of the original tumo......
期刊： JOURNAL OF BREAST CANCER, 2021; 24 (3)
Purpose: Triple-negative breast cancer (TNBC) is the most lethal subtype of breast cancer owing to high heterogeneity, aggressive nature, and lack of ......
期刊： JOURNAL OF BREAST CANCER, 2021; 24 (3)
Purpose: Non-coding RNA activated by DNA damage (NORAD) has been reported to be a cancer-related long non-coding RNA (lncRNA) implicated in the progre......
期刊： JOURNAL OF BREAST CANCER, 2021; 24 (4)
Purpose: The purpose of the current study was to explore the functions and potential mechanism of miR-451a in breast cancer (BC). Methods: Quantitativ......
期刊： JOURNAL OF BREAST CANCER, 2021; 24 (3)
Tumor localization is challenging in the context of ductal carcinoma in situ (DCIS) treated with breast-conserving surgery. Conventional localization ......
期刊： JOURNAL OF BREAST CANCER, 2020; 23 (1)
Purpose: Tau is a microtubule-associated protein that can be found in both normal and abnormal breast cells. Whether the expression of Tau protein can......
期刊： JOURNAL OF BREAST CANCER, 2020; 23 (2)
Purpose: C-X-C motif chemokine receptor 4 (CXCR4) and integrin alpha v beta 6 play important roles in the malignant progression of multiple cancers. H......
期刊： JOURNAL OF BREAST CANCER, 2020; 23 (2)
Purpose: Numerous studies have shown that the frequency of myeloid-derived suppressor cells (MDSCs) is associated with tumor progression, metastasis, ......
期刊： JOURNAL OF BREAST CANCER, 2020; 23 (2)
As a standard treatment, endocrine therapy has dramatically enhanced the prognosis of patients with estrogen receptor (ER)-positive breast cancer, whi......
期刊： JOURNAL OF BREAST CANCER, 2020; 23 (3)
Purpose: Effective predictors of the response to neoadjuvant chemotherapy (NAC) are still insufficient. This study aimed to investigate the predictive......
期刊： JOURNAL OF BREAST CANCER, 2020; 23 (4)
Purpose: Combining targeted agents with adjuvant chemotherapy prolongs survival in human epidermal growth factor receptor 2 (HER2)-positive breast can......
期刊： JOURNAL OF BREAST CANCER, 2020; 23 (4)
Purpose: Real-time detection and intervention can be used as potential measures to markedly decrease breast cancer mortality. Assessment of circulatin......
期刊： JOURNAL OF BREAST CANCER, 2020; 23 (4)
Purpose: Four and a half LIM protein 1 (FHL1) is involved in breast cancer (BC) development, but the regulatory mechanism involved remain unclear. In ......
